Weight-Loss Drugs Fuel Chemist Warehouse Sales Surge
Demand for blockbuster weight-loss drugs, particularly GLP-1 receptor agonists, is driving significant sales growth at Chemist Warehouse, with the trend expected to accelerate as more affordable options grow available in the Australian market. This surge in demand has positively impacted the company’s parent, Sigma Healthcare, with shares rising following strong financial results.
Chemist Warehouse Reports Double-Digit Sales Growth
Sigma Healthcare reported accelerated sales growth in the second quarter of the fiscal year, continuing into the third quarter, largely attributed to the booming demand for anti-obesity medications as reported by the Australian Financial Review. Shares in Sigma Healthcare increased by 2.3 per cent to $3.06 on Thursday, February 26, 2026, following the announcement.
GLP-1s: An Enduring Trend
Unlike previous temporary boosts in sales, such as those seen with rapid antigen tests during the COVID-19 pandemic, the demand for GLP-1 drugs is expected to be more sustained. Stockhead reports that Sigma Healthcare CEO Vikesh Ramsunder believes this is “not a RAT test or anything like that,” suggesting an “enduring” benefit. Further innovations, including the anticipated release of oral doses, are expected to expand the market and lower treatment costs.
Impact of Potential PBS Listing
A potential risk to current margins is the possibility of GLP-1 drugs being added to the Pharmaceutical Benefits Scheme (PBS). While a PBS listing would broaden access for patients, it could likewise reduce Chemist Warehouse’s ability to compete on price as noted by Stockhead.
Continued Momentum and Expansion
Sigma Healthcare is experiencing strong business momentum that began in the final quarter of fiscal year 2025 and is continuing into the current financial year according to the Australian Journal of Pharmacy. The company also plans to continue expanding its network of Chemist Warehouse, Amcal, and Discount Drug store outlets, including further international expansion.
Ozempic and GLP-1 Drug Demand
Prescriptions for Ozempic and other GLP-1 drugs are significantly contributing to Chemist Warehouse’s sales surge as reported by the Herald Sun.